Profil
Xiao Lin Wang worked as the VP-Biometrics & Development Operations at Geron Corp.
from 2010 to 2015.
From 2015 to 2018, she held the position of Vice President-Biometrics at Acerta Pharma LLC.
Currently, she is the Executive Vice President-Clinical Development at Revolution Medicines, Inc. starting from 2018.
Dr. Wang holds a doctorate degree from Harvard University, a graduate degree from the University of Washington, and an undergraduate degree from Peking University.
Anciens postes connus de Xiao Lin Wang
| Sociétés | Poste | Fin |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
| Acerta Pharma LLC | Corporate Officer/Principal | 01/03/2018 |
| GERON CORPORATION | Corporate Officer/Principal | 01/05/2015 |
Formation de Xiao Lin Wang
| Harvard University | Doctorate Degree |
| University of Washington | Graduate Degree |
| Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
42
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Acerta Pharma LLC |
